γδT Cells Immunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

Clinical trial NCT04028440 · UNKNOWN

Trial details

NCT number: NCT04028440
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma Relapsed or Refractory B Cell Non-Hodgkin's Lymphoma Chronic Lymphoblastic Leukemia Peripheral T Cell Lymphoma

Start date: 2019-10-01
Primary completion: 2020-12-31
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.